PCSK9 inhibition could ameliorate cardiovascular disease by immune mechanisms

(European Society of Cardiology) PCSK9 inhibition could ameliorate atherosclerosis and thus cardiovascular disease by immune mechanisms that are unrelated to lowering of low-density lipoprotein (LDL) cholesterol, according to research presented today at ESC Congress.

from EurekAlert! - Social and Behavioral Science http://ift.tt/2gj0i6Y